These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34179315)

  • 1. Bone morphogenetic protein 4 (BMP4) promotes hepatic glycogen accumulation and reduces glucose level in hepatocytes through mTORC2 signaling pathway.
    An L; Shi Q; Zhu Y; Wang H; Peng Q; Wu J; Cheng Y; Zhang W; Yi Y; Bao Z; Zhang H; Luo Y; Fan J
    Genes Dis; 2021 Jul; 8(4):531-544. PubMed ID: 34179315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes.
    Peng Q; Chen B; Wang H; Zhu Y; Wu J; Luo Y; Zuo G; Luo J; Zhou L; Shi Q; Weng Y; Huang A; He TC; Fan J
    Aging (Albany NY); 2019 Dec; 11(23):11520-11540. PubMed ID: 31831718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease.
    Li T; Huang X; Yue Z; Meng L; Hu Y
    Cell Biochem Funct; 2020 Oct; 38(7):839-846. PubMed ID: 32212193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Role of Bone Morphogenetic Protein 4 in Metabolic Disorders.
    Baboota RK; Blüher M; Smith U
    Diabetes; 2021 Feb; 70(2):303-312. PubMed ID: 33472940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro.
    Mahli A; Seitz T; Beckröge T; Freese K; Thasler WE; Benkert M; Dietrich P; Weiskirchen R; Bosserhoff A; Hellerbrand C
    Cells; 2019 May; 8(5):. PubMed ID: 31096638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease.
    Qiao JT; Cui C; Qing L; Wang LS; He TY; Yan F; Liu FQ; Shen YH; Hou XG; Chen L
    Metabolism; 2018 Apr; 81():13-24. PubMed ID: 29106945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
    Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
    Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coniferaldehyde ameliorates the lipid and glucose metabolism in palmitic acid-induced HepG2 cells via the LKB1/AMPK signaling pathway.
    Gai H; Zhou F; Zhang Y; Ai J; Zhan J; You Y; Huang W
    J Food Sci; 2020 Nov; 85(11):4050-4060. PubMed ID: 33037652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branched-Chain Amino Acids Exacerbate Obesity-Related Hepatic Glucose and Lipid Metabolic Disorders via Attenuating Akt2 Signaling.
    Zhao H; Zhang F; Sun D; Wang X; Zhang X; Zhang J; Yan F; Huang C; Xie H; Lin C; Liu Y; Fan M; Yan W; Chen Y; Lian K; Li Y; Zhang L; Wang S; Tao L
    Diabetes; 2020 Jun; 69(6):1164-1177. PubMed ID: 32184272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease.
    Chen G
    Curr Drug Targets; 2015; 16(12):1281-92. PubMed ID: 25808650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodiola crenulata extract regulates hepatic glycogen and lipid metabolism via activation of the AMPK pathway.
    Lin KT; Hsu SW; Lai FY; Chang TC; Shi LS; Lee SY
    BMC Complement Altern Med; 2016 May; 16():127. PubMed ID: 27184670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
    J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.
    Monteillet L; Gjorgjieva M; Silva M; Verzieux V; Imikirene L; Duchampt A; Guillou H; Mithieux G; Rajas F
    Mol Metab; 2018 Oct; 16():100-115. PubMed ID: 30100243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP4 upregulates glycogen synthesis through the SMAD/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells.
    Zhong J; Tian L; Gou Y; Zhao P; Dong X; Guo M; Zhao G; Li A; Hao A; He TC; Fan J
    Cancer Metab; 2023 Jul; 11(1):9. PubMed ID: 37443106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism.
    Yang M; Liang Z; Yang M; Jia Y; Yang G; He Y; Li X; Gu HF; Zheng H; Zhu Z; Li L
    FASEB J; 2019 Sep; 33(9):10077-10088. PubMed ID: 31237775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
    Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
    Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
    Lu C; Zhang F; Xu W; Wu X; Lian N; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
    IUBMB Life; 2015 Aug; 67(8):645-58. PubMed ID: 26305715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling.
    Javary J; Allain-Courtois N; Saucisse N; Costet P; Heraud C; Benhamed F; Pierre R; Bure C; Pallares-Lupon N; Do Cruzeiro M; Postic C; Cota D; Dubus P; Rosenbaum J; Benhamouche-Trouillet S
    Gut; 2018 Dec; 67(12):2192-2203. PubMed ID: 29074727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.